Effect of Valsartan on Carotid Artery Disease

Completed · Phase 2 · Has a placebo group

Conditions studied: Carotid Artery Diseases, Atherosclerosis

In brief

The EFFERVESCENT trial is designed to evaluate the effects of a specific ARB, called valsartan, on atherosclerosis. The investigators want to know if treatment with valsartan will increase the blood levels of markers responsible for repair of the vessel wall, reduce oxidation and inflammation, improve the function of the blood vessels, and arrest or slow down the progression of atherosclerosis over time.

Key facts

Study ID

NCT00208767

Run by

Emory University

People needed

120

Starts

2005-02-01

Expected to finish

2009-11-01

Last updated by the study team

2015-12-08

Who can join

Age: 21 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• > 0.65 mm intima-media thickness of the carotid artery measured by ultrasound
• Males aged 21-80 years or women without child bearing potential up to age 80
• Can be on concomitant therapy with aspirin, thiazide diuretics, calcium antagonists (for treatment of hypertension), or beta-receptor antagonists.
• May be on statin if on stable dose for at least 2 months before recruitment

You may not qualify if…

• Angiotensin-converting enzyme (ACE) inhibitor or ARB therapy in the previous 3 months.
• Initiation or change in dose of statin therapy within 2 months before the study
• Inability to return to Emory for follow-up blood drawing and MR imaging
• Age < 21 or > 80 years
• Premenopausal females with potential for pregnancy
• Current neoplasm
• Chronic renal failure [creatinine > 2.5 mg/dL]
• Diabetes with hemoglobin (Hb) A1c > 8.5
• Anticipated change in lipid lowering therapy
• Inability to give informed consent
• MR exclusion criteria
• Blood pressure > 140 mmHg systolic and > 90 mmHg diastolic
• Low-density lipoprotein (LDL) cholesterol level >130 mg/dl
• Acute coronary syndrome within 2 months
• Acute cerebrovascular accident within 2 months

Where it is running

• Emory University School of Medicine — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.